-
The Access 2 Immunology system contains the robustness of a reference laboratory analyzer in the convenient size of a benchtop system while, providing greater control over performance, reliability and speed without the sacrifice of valuable Laboratory Space.
-
The AU480 chemistry analyser is the ideal Clinical Chemistry Analyzer that will allow you to enhance your Laboratory efficiency through a powerful and robust system. Ideal for low- to mid-volume hospitals and laboratories, or as a dedicated specialty chemistry or STAT analyser the AU480 can outperform any analyser in its class, with a throughput of up to 400 photometric tests per hour (up to 800 with ISEs), increased onboard testing, reduced sample volume and easy operation. The capabilities are endless as this analyser will allow you to:
- Broaden your test offerings with more than 120 different Beckman Coulter system reagent applications available
- Conduct quick priority testing using the AU 480 clinical chemistry analyzer’s STAT wheel
- Turn around critical samples fast with sample pre-dilution and auto-repeat of over-range results
-
Streamline workflow and maximize staff walkaway time with the DxH 690T haematology analyser. This 5-part differential CBC analyser helps you give your patients rapid results, while enabling your technologists to simplify processes and reduce manual tasks. The benchtop system includes the same automated capabilities and industry-leading 93% first-pass yield of our full-featured DxH 900 haematology analyzer,1 as well as support for the Early Sepsis Indicator (ESId) haematology biomarker for sepsis. Available exclusively for mid-volume laboratories on the DxH 690T, the ESId helps clinicians identify sepsis in the emergency department (ED) to support faster, targeted treatment.
-
The right results, the first time The DxH 900 hematology analyzer enables your high-volume laboratory to achieve superb RBC, PLT and WBC differentials through near native-state cellular characterization. Industry-leading 93% first-pass yield* ensures predictable costs and a faster break-even point. Streamlined processes help your laboratory maximize staff time through the most reportable results per square meter in the industry, fewer slide reviews and high system reliability for greater uptime.
-
Organisms possessing Extended-Spectrum Beta-Lactamases (ES?L) may be clinically resistant to therapy with penicillins, cephalosporins, and aztreonam, despite apparent in vitro susceptibility to some of these agents. The incidence of these strains is on the rise and is a significant health concern in some regions. Because of this, the screening and confirmation of ES?L-producing strains is recommended by all major national guidelines.
-
The autoSCAN-4 System processes panels in seconds, simplifying identification and antibiotic susceptibility testing (ID/AST) while standardizing results. Over 30 years of exceptional instrument reliability and our conventional panel technology – with the fewest FDA limitations in automated ID/AST – make the autoSCAN-4 an excellent supplemental system for difficult organisms or as a primary instrument for low-volume usage.
-
As the foundation of our identification and antibiotic susceptibility testing (ID/AST) products, Conventional panels deliver accuracy, choice, and flexibility. With the fewest FDA limitations of leading automated ID/AST systems, use of conventional panels reduces supplemental testing costs and reporting delays associated with rapid only systems.
- Direct minimum inhibitory concentration (MIC) susceptibility methodology helps ensure detection of emerging and low-level resistance, while combo ID/AST formats provide creative workflow solutions.
- Our exclusive, PROMPT™ inoculation method with 4-hour stability reduces inoculum preparation time by over 40% when compared to turbidity methods.
-
The WalkAway plus System delivers gold-standard accuracy for microorganism identification and susceptibility testing. This system delivers accurate emerging resistance detection for the toughest pathogens, including VISA, VRSA, and MRSA.
-
Healthcare professionals are faced with a variety of significant fastidious pathogens where resistance to an extensive number of antibiotics is rapidly on the rise. This can lead to complications ranging from pediatric ear infections to life-threatening conditions such as meningitis or sepsis. For appropriate antimicrobial therapy, accurate minimum inhibitory concentration (MIC) testing should be assessed for all significant isolates.
-
A definitive identification (ID) in as little as 2.5 hours coupled with your hospital antibiogram provides rapid empiric therapy guidance. A good choice for common, high volume, gram-negative organisms – MicroScan Rapid panels achieve same day turnaround time for routine isolates.
-
Specialty ID panels provide same-day identification of yeast, Haemophilus/Neisseria, and anaerobic bacteria. The technology tests for the presence of pre-formed enzymes used by the organism to metabolize various substrates.
-
Efficient operation for exceptional productivity in the hospital lab Scale your immunoassay laboratory efficiently. The UniCel DxI 600 Access Immunoassay System helps laboratories running 40,000-80,000 tests per year meet peak workload demands with throughput of up to 200 tests per hour and up to 60 samples on board. Streamlined maintenance procedures mean your analyzer is available when you need it. “Load and go” simplicity frees up staff for higher value work—no pausing or standby time required. Virtually any technologist can run tests and perform routine tasks easily using the analyzer’s industry-leading intuitive interfaces. Connect the DxI 600 immunoassay analyzer to automation tracks and clinical informatics systems to further enhance efficiency throughout the laboratory.
